Perception of Quality of Life by Patients, Partners and Treating Physicians

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2001 May 3

PMID 11332225

Citations 84

Authors

K A Wilson

A J Dowling

M Abdolell

I F Tannock

Affiliations

Soon will be listed here.

Abstract

The objective of the study was to determine possible differences in perception of quality of life (QoL) between patients with metastatic breast or prostate cancer, their partners, and the treating physician. Patients with metastatic breast cancer (n = 71), and metastatic prostate cancer (n = 29), a partner, and the physician each completed the same QoL questionnaire indicating how they perceived the patient's QoL. The European organization for research and treatment of cancer (EORTC) QLQ-C30 questionnaire was used to assess patients with breast cancer and the modified prostate cancer specific quality of life instrument (PROSQOLI) for patients with prostate cancer. There was reasonable agreement in mean scores between patients, and physicians or partners, for many domains of QoL; however, there was substantial discordance between scores when considering individual patients. For patients with metastatic breast cancer, physicians systematically underestimated overall QoL (p = 0.0002), social functioning (p = 0.001), and role functioning (p = 0.008), while partners showed better agreement. With prostate cancer physicians tended to underestimate pain, while mean scores for spouses were more concordant. There is substantial variability between ratings of QoL by physicians or partners, as compared to patient ratings. Medical decisions should be based on information about QoL provided by patients using validated methods.

Citing Articles

Reliability and validity of the adapted Finnish version of the early onset scoliosis questionnaire (EOSQ-24).

Haapala H, Salonen A, Suominen E, Syvanen J, Repo J, Matsumoto H Spine Deform. 2024; 12(4):1137-1143.

PMID: 38578600 PMC: 11217041. DOI: 10.1007/s43390-024-00861-8.

Validation of the AO Spine CROST (Clinician Reported Outcome Spine Trauma) in the clinical setting.

Sadiqi S, de Gendt E, Muijs S, Post M, Benneker L, Holas M Eur Spine J. 2024; 33(4):1607-1616.

PMID: 38367026 DOI: 10.1007/s00586-024-08145-5.

Experts' Perceived Patient Burden and Outcomes of Knee-ankle-foot-orthoses (Kafos) Vs. Microprocessor-stance-and-swing-phase-controlled-knee-ankle-foot Orthoses (Mp-sscos).

Bruggenjurgen B, Braatz F, Greitemann B, Drewitz H, Ruetz A, Schafer M Can Prosthet Orthot J. 2023; 5(1):37795.

PMID: 37614478 PMC: 10443469. DOI: 10.33137/cpoj.v5i1.37795.

Patient quality of life and caregiver experiences in ovarian cancer: How are they related?.

Stragapede E, Petricone-Westwood D, Hales S, Galica J, Lebel S Qual Life Res. 2023; 32(12):3521-3529.

PMID: 37535264 DOI: 10.1007/s11136-023-03481-3.

Current status of patient-reported outcome measures and other subjective assessment grading tools in bladder pain syndrome.

Uguzova S, Juliebo-Jones P, Beisland C, Haq A Int Urogynecol J. 2023; 34(8):1677-1687.

PMID: 37129626 DOI: 10.1007/s00192-023-05551-z.

References

. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol. 1996; 14(2):671-9. DOI: 10.1200/JCO.1996.14.2.671. View

Bartko J . The intraclass correlation coefficient as a measure of reliability. Psychol Rep. 1966; 19(1):3-11. DOI: 10.2466/pr0.1966.19.1.3. View

Blazeby J, Williams M, Alderson D, Farndon J . Observer variation in assessment of quality of life in patients with oesophageal cancer. Br J Surg. 1995; 82(9):1200-3. DOI: 10.1002/bjs.1800820916. View

Dixon J, Bird H . Reproducibility along a 10 cm vertical visual analogue scale. Ann Rheum Dis. 1981; 40(1):87-9. PMC: 1000664. DOI: 10.1136/ard.40.1.87. View

Stockler M, Osoba D, Goodwin P, Corey P, Tannock I . Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module..... J Clin Epidemiol. 1998; 51(2):137-45. DOI: 10.1016/s0895-4356(97)00269-2. View

Grossman S, Sheidler V, Swedeen K, Mucenski J, Piantadosi S . Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage. 1991; 6(2):53-7. DOI: 10.1016/0885-3924(91)90518-9. View

Schipper H, Clinch J, McMurray A, Levitt M . Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol. 1984; 2(5):472-83. DOI: 10.1200/JCO.1984.2.5.472. View

Rothman M, Hedrick S, Bulcroft K, Hickam D, Rubenstein L . The validity of proxy-generated scores as measures of patient health status. Med Care. 1991; 29(2):115-24. DOI: 10.1097/00005650-199102000-00004. View

Epstein A, Hall J, Tognetti J, Son L, Conant Jr L . Using proxies to evaluate quality of life. Can they provide valid information about patients' health status and satisfaction with medical care?. Med Care. 1989; 27(3 Suppl):S91-8. View

10.

Stockler M, Osoba D, Corey P, Goodwin P, Tannock I . Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for.... J Clin Epidemiol. 1999; 52(7):653-66. DOI: 10.1016/s0895-4356(99)00025-6. View

11.

Hays R, Vickrey B, Hermann B, Perrine K, Cramer J, Meador K . Agreement between self reports and proxy reports of quality of life in epilepsy patients. Qual Life Res. 1995; 4(2):159-68. DOI: 10.1007/BF01833609. View

12.

Kantoff P, Halabi S, Conaway M, Picus J, Kirshner J, Hars V . Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. J Clin Oncol. 1999; 17(8):2506-13. DOI: 10.1200/JCO.1999.17.8.2506. View

13.

Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

14.

Spitzer W, Dobson A, Hall J, Chesterman E, Levi J, Shepherd R . Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis. 1981; 34(12):585-97. DOI: 10.1016/0021-9681(81)90058-8. View

15.

Sneeuw K, Aaronson N, Osoba D, Muller M, Hsu M, Yung W . The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care. 1997; 35(5):490-506. DOI: 10.1097/00005650-199705000-00006. View

16.

Rogers J, Ridley S, Chrispin P, Scotton H, Lloyd D . Reliability of the next of kins' estimates of critically ill patients' quality of life. Anaesthesia. 1998; 52(12):1137-43. DOI: 10.1111/j.1365-2044.1997.240-az0374.x. View

17.

Sneeuw K, Aaronson N, Sprangers M, Detmar S, Wever L, Schornagel J . Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses. Br J Cancer. 1999; 81(1):87-94. PMC: 2374350. DOI: 10.1038/sj.bjc.6690655. View

18.

Presant C . Quality of life in cancer patients. Who measures what?. Am J Clin Oncol. 1984; 7(5):571-3. DOI: 10.1097/00000421-198410000-00036. View

19.

Silva F, Reis E, Costa T, Denis L . Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group. Cancer. 1993; 71(3 Suppl):1138-42. DOI: 10.1002/1097-0142(19930201)71:3+<1138::aid-cncr2820711436>3.0.co;2-7. View

20.

Tannock I, Osoba D, Stockler M, Ernst D, Neville A, Moore M . Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol. 1996; 14(6):1756-64. DOI: 10.1200/JCO.1996.14.6.1756. View